Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing Remitting Multiple Sclerosis”

741 trials

Showing 20 of 741 results

Not applicableStudy completedNCT03302442
What this trial is testing

Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Nantes University Hospital 3,000
Large-scale testing (Phase 3)Study completedNCT01874145
What this trial is testing

Safety and Tolerability of Glatiramer Acetate

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 209
Not applicableStudy completedNCT03244696
What this trial is testing

Behavior and Activity Monitoring in MS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Ohio State University 87
Testing effectiveness (Phase 2)Study completedNCT01071083
What this trial is testing

Treatment Interruption of Natalizumab

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 175
Testing effectiveness (Phase 2)Study completedNCT05131828
What this trial is testing

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Who this might be right for
Multiple Sclerosis
Cambridge University Hospitals NHS Foundation Trust 70
Large-scale testing (Phase 3)UnknownNCT02220244
What this trial is testing

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MedDay Pharmaceuticals SA 105
Post-approval studies (Phase 4)Study completedNCT01333501
What this trial is testing

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 151
Testing effectiveness (Phase 2)Study completedNCT02410200
What this trial is testing

Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 22
Not applicableNot Yet RecruitingNCT07645937
What this trial is testing

Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
Hanifi Bal 30
Large-scale testing (Phase 3)Study completedNCT02746744
What this trial is testing

RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Anders Svenningsson 200
Testing effectiveness (Phase 2)Study completedNCT00203112
What this trial is testing

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

Who this might be right for
Relapse Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 44
Not applicableActive Not RecruitingNCT07757568
What this trial is testing

Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fumarate (Tecfidera) or Diroximel Fumarate (Vumerity)

Who this might be right for
Multiple Sclerosis (MS) Relapsing Remitting
University of Colorado, Denver 11
Early research (Phase 1)Study completedNCT01808885
What this trial is testing

Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Hoffmann-La Roche 44
Not applicableStudy completedNCT03758820
What this trial is testing

Behavior Cognitive Therapy on Fatigue Impact in MS Patients

Who this might be right for
Relapsing Remitting Multiple SclerosisFatigueCognitive Therapy
Réseau Sep Idf Ouest 105
Large-scale testing (Phase 3)Ended earlyNCT03870763
What this trial is testing

Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 11
Not applicableStudy completedNCT04858763
What this trial is testing

MS Relapses During COVID-19 Pandemic

Who this might be right for
Multiple SclerosisCovid19Relapsing Remitting Multiple Sclerosis
Nottingham University Hospitals NHS Trust 51
Testing effectiveness (Phase 2)Study completedNCT00882999
What this trial is testing

Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Eli Lilly and Company 245
Not applicableActive Not RecruitingNCT05811416
What this trial is testing

Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Bristol-Myers Squibb 200
Not applicableUnknownNCT03508414
What this trial is testing

Nutritional Approaches in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Charite University, Berlin, Germany 111
Not applicableUnknownNCT06303024
What this trial is testing

Targeting Subclinical Motor and Cognitive Impairment in Patients With Early Onset Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Fondazione Don Carlo Gnocchi ETS 140
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation